We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-11.62%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.03B
AUM Growth
-$132M
Cap. Flow
+$20.6M
Cap. Flow %
2.01%
Top 10 Hldgs %
29.82%
Holding
462
New
17
Increased
58
Reduced
119
Closed
62

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$11.1M
2
GEN icon
Gen Digital
GEN
+$9.34M
3
GRMN
Garmin
GRMN
+$9.3M
4
UNFI icon
United Natural Foods
UNFI
+$9.22M
5
AMGN icon
Amgen
AMGN
+$5.68M

Top Sells

Rank Stock Value
1
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$8.97M
2
MA icon
Mastercard
MA
+$4.79M
3
GEM icon
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
+$4.72M
4
TMO icon
Thermo Fisher Scientific
TMO
+$3.8M
5
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3.74M

Sector Composition

Rank Sector Weight
1 Healthcare 17.34%
2 Technology 16.69%
3 Industrials 11.06%
4 Financials 10.91%
5 Consumer Discretionary 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
151
DexCom
DXCM
$31.4B
$149K 0.01%
2,000
– –
DUK icon
152
Duke Energy
DUK
$95.8B
$148K 0.01%
1,380
-33
-2% -$3.63K
AVGO icon
153
Broadcom
AVGO
$2T
$143K 0.01%
2,940
– –
SEE
154
DELISTED
Sealed Air
SEE
$139K 0.01%
2,400
– –
ED icon
155
Consolidated Edison
ED
$39.6B
$136K 0.01%
1,432
– –
ENR icon
156
Energizer
ENR
$1.55B
$134K 0.01%
4,742
– –
ECL icon
157
Ecolab
ECL
$79.8B
$133K 0.01%
867
-32
-4% -$5.31K
LLY icon
158
Eli Lilly
LLY
$1.04T
$128K 0.01%
395
-5
-1% -$1.5K
GIS icon
159
General Mills
GIS
$19.1B
$123K 0.01%
1,636
-40
-2% -$2.8K
FXH icon
160
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$112K 0.01%
1,090
– –
AEE icon
161
Ameren
AEE
$30B
$108K 0.01%
1,200
– –
EW icon
162
Edwards Lifesciences
EW
$51.2B
$106K 0.01%
1,114
+202
+22% +$20.9K
FXO icon
163
First Trust Financials AlphaDEX Fund
FXO
$1.15B
$106K 0.01%
2,725
– –
ANET icon
164
Arista Networks
ANET
$251B
$105K 0.01%
4,500
-700
-13% -$19.2K
POST icon
165
Post Holdings
POST
$4.08B
$104K 0.01%
1,268
– –
SLV icon
166
iShares Silver Trust
SLV
$30B
$103K 0.01%
5,525
– –
EFSC icon
167
Enterprise Financial Services Corp
EFSC
$2.42B
$102K 0.01%
2,460
– –
CALY
168
Callaway Golf Company
CALY
$3.45B
$102K 0.01%
5,000
– –
CP icon
169
Canadian Pacific Kansas City
CP
$80.5B
$101K 0.01%
1,442
– –
EMN icon
170
Eastman Chemical
EMN
$8.38B
$99K 0.01%
1,100
– –
CW icon
171
Curtiss-Wright
CW
$27.9B
$94K 0.01%
715
-20
-3% -$2.84K
BX icon
172
Blackstone
BX
$108B
$91K 0.01%
1,000
– –
TT icon
173
Trane Technologies
TT
$106B
$91K 0.01%
700
+500
+250% +$69.1K
VEEV icon
174
Veeva Systems
VEEV
$34.5B
$91K 0.01%
460
– –
AJG icon
175
Arthur J. Gallagher & Co
AJG
$64.1B
$90K 0.01%
551
-49
-8% -$8.13K
5 6
7
8 9

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2022 Portfolio in Review

As of Q2 2022, Atwood & Palmer held 462 positions worth $1.03B, down 11% from $1.16B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atwood & Palmer's Q2 2022 filing shows 17 new, 58 increased, 119 reduced and 62 closed positions. Its largest new stake was United Therapeutics: 54,788 shares worth $12.9M. The largest sale was iShares Preferred and Income Securities ETF, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Atwood & Palmer's largest Q2 2022 buy was United Therapeutics: 54,788 shares worth $12.9M.
  • Atwood & Palmer added most to Garmin in Q2 2022, an estimated $9.3M increase.
  • Atwood & Palmer's biggest Q2 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $8.97M.
  • Atwood & Palmer fully exited Cerner Corp in Q2 2022, selling an estimated $624K.
  • Atwood & Palmer's ten largest holdings make up 30% of its $1.03B portfolio in Q2 2022.
  • Atwood & Palmer opened 17 new positions and closed 62 in Q2 2022.
  • Atwood & Palmer's portfolio value fell 11% quarter-over-quarter to $1.03B.

Based on Atwood & Palmer's 13F filing for Q2 2022, filed 21 Jul 2022.